Is MCVEF or EQR a better dividend investment in 2026?

MCVEF currently yields 0.62% with a 5% 5-year dividend growth rate. EQR yields 4.73% with 5% growth. The better choice depends on your goal: EQR offers higher current income.

What is the dividend yield difference between MCVEF and EQR?

MCVEF has a forward dividend yield of 0.62% ($0.17/share annually). EQR yields 4.73% ($2.77/share annually). The yield gap is 4.11 percentage points.

Home › Compare › MCVEF vs EQR

MCVEF vs EQR: Dividend Comparison 2026

MCVEF yields 0.62% · EQR yields 4.73%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EQR wins by $19.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MCVEF

● Live price

0.62%

Share price

$27.25

Annual div

$0.17

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.6K

Annual income

$64.97

Full MCVEF calculator →

EQR

● Live price

4.73%

Share price

$58.58

Annual div

$2.77

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.5K

Annual income

$3,819.61

Full EQR calculator →

Portfolio growth — MCVEF vs EQR

📍 EQR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MCVEF	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MCVEF + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MCVEF pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCVEF

Annual income on $10K today (after 15% tax)

$53.03/yr

After 10yr DRIP, annual income (after tax)

$55.22/yr

EQR

Annual income on $10K today (after 15% tax)

$401.93/yr

After 10yr DRIP, annual income (after tax)

$3,246.67/yr

At 15% tax rate, EQR beats the other by $3,191.44/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCVEF + EQR for your $10,000?

MCVEF: 50%EQR: 50%

100% EQR50/50100% MCVEF

Portfolio after 10yr

$30.5K

Annual income

$1,942.28/yr

Blended yield

6.37%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

MCVEF

No analyst data

Altman Z

2.3

Piotroski

6/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+20.1% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCVEF buys

EQR buys

No recent congressional trades found for MCVEF or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMCVEFEQR

Forward yield	0.62%	4.73% ✓
Annual dividend / share	$0.17	$2.77 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$20.6K	$40.5K ✓
Annual income after 10y	$64.97	$3,819.61 ✓
Total dividends collected	$638.00 ✓	$16.9K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: MCVEF vs EQR ($10,000, DRIP)

Year	MCVEF Portfolio	MCVEF Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$10,762	$62.39	$11,248	$547.57	$486.00 → EQR
2	$11,579	$62.75	$12,701	$666.53	$1.1K → EQR
3	$12,452	$63.09	$14,405	$814.59	$2.0K → EQR
4	$13,387	$63.41	$16,413	$999.84	$3.0K → EQR
5	$14,388	$63.71	$18,795	$1,232.92	$4.4K → EQR
6	$15,459	$64.00	$21,639	$1,527.95	$6.2K → EQR
7	$16,606	$64.26	$25,057	$1,903.80	$8.5K → EQR
8	$17,832	$64.51	$29,197	$2,385.87	$11.4K → EQR
9	$19,145	$64.75	$34,250	$3,008.70	$15.1K → EQR
10	$20,551	$64.97	$40,467	$3,819.61	$19.9K → EQR

MCVEF vs EQR: Complete Analysis 2026

MCVEF — Stock

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Full MCVEF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this MCVEF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCVEF vs SCHD MCVEF vs JEPI MCVEF vs O MCVEF vs KO MCVEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.